Accordingly, the aggressive phenotype of rhabdomyosarcoma was shown to be reduced by treatment with HO-1 inhibitors [106], and other studies suggested that the use of ZnPP can increase the sensitivity and susceptibility to chemotherapy of hepatoma cells [39] and ex vivo samples obtained from multiple myeloma patients [107]. This evidence concerns the gene HMOX1 and AL amyloidosis.